Abstract
Summary: First reported case of primary central nervous system infantile fibrosarcoma. Expansion of the molecular spectrum of infantile fibrosarcoma with identification of an RBPMS::NTRK3 fusion. Marked efficacy of larotrectinib observed in an unresectable CNS tumour. Reinforces the importance of molecular testing in atypical paediatric CNS tumours.

This publication has 12 references indexed in Scilit: